Cogent Biosciences, Inc.

COGT: Is Cogent Biosciences, Inc. Halal?

Cogent Biosciences, Inc.

NASDAQHealthcareUS

$34.68

-0.91%

Market Cap: 5.9B

Compliance Status

Halal

Screened on Sep 2, 2026 · AAOIFI Standard 21

A

Very Good

84Score

Is Cogent Biosciences, Inc. (COGT) halal? Halal. Based on AAOIFI screening, Cogent Biosciences, Inc. passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 84/100 (Grade: A).

Quote this verdict

HalalScreener rates Cogent Biosciences, Inc. (COGT) Halal, 84/100, grade A under AAOIFI Standard 21, screened Sep 2, 2026. Source: https://halalscreener.app/en/stock/COGT

Business activity

What the company sells is permissible.

Passed

Company debt

Well clear of the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

4.3% of 30.0% limit

What this means for you

You can own COGT

It passes both the business activity and financial ratio screens under AAOIFI Standard 21.

Purification amount is Pro

We have screened COGT's prohibited income, but the exact share you would need to purify is part of Pro.

About Cogent Biosciences, Inc.

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.

Sector: Healthcare · Industry: Biotechnology

Shariah Compliance Status

AAOIFI Standard 21Updated Sep 2, 2026

Compliance History

  1. Halalnow

    since Aug 2026

  2. Under Review

    until the change above

  3. Halal

    until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Fiscal: FY 2025Data source: FMP
Free · No credit card required

Track COGT and 6,200+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

6,200+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Cogent Biosciences, Inc. (COGT) halal to invest in?
Based on AAOIFI Standard 21 screening, Cogent Biosciences, Inc. (COGT) is rated Halal with a compliance grade of A (Very Good). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).
Why did Cogent Biosciences, Inc. get a A compliance rating?
Cogent Biosciences, Inc. (COGT) received a grade of A (Very Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 4.3% (limit 30%). The grade reflects the margin of safety across all three ratios relative to their thresholds.
What could change Cogent Biosciences, Inc.'s Shariah verdict?
Cogent Biosciences, Inc.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.
How often is Cogent Biosciences, Inc. re-screened for Shariah compliance?
Cogent Biosciences, Inc. (COGT) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Sep 2, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.